Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 2, 2009Neurology

Donepezil Treatment of Patients With McI: A 48-Week Randomized, Placebo- Controlled Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPaul K. CraneBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Paul K. Crane (2009) studied this question.

synapsesocial.com/papers/6a6baea2050bc01bbbcb7afehttps://doi.org/10.1212/wnl.0b013e3181bd6c25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change1997 · 655 citations
  2. 2Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease2001 · 1,875 citations
  3. 3The Physiology and Pharmacology of Melatonin in Humans1998 · 164 citations
  4. 4Efficacy of donepezil in mild cognitive impairment2004 · 305 citations
  5. 5A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD2001 · 732 citations